Share
When you hear the words Alzheimer's disease, what do you think of? The truth is, the picture most of us have of the disease is incomplete. Alzheimer's disease doesn't start when someone starts to lose their memory. It actually starts years – sometimes decades – earlier. The Rethinking Alzheimer's Disease Podcast is an engaging, narrative-style podcast miniseries for those curious or motivated to learn about Alzheimer’s disease. Perhaps you have a family member with Alzheimer’s disease, or ca ...
…
continue reading
Manage episode 522104455 series 2893730
Content provided by Saul Marquez. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Saul Marquez or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.
This podcast is brought to you by Outcomes Rocket, your exclusive healthcare marketing agency. Learn how to accelerate your growth by going to outcomesrocket.com
Innovation is moving faster than the law, and investors are racing to keep up.
In this episode, Brian Bewley, a partner in the Life Sciences and Health Industry group at Reed Smith, discusses how rapid technological advancements are reshaping healthcare and the life sciences faster than current regulations can keep pace. He explains how shifting federal policies, tariff disruptions, and turnover at key agencies, such as the FDA and HHS, have created uncertainty for investors. Brian also discusses how state-level laws are making it harder for private equity to fund healthcare innovation, and why that could slow progress. Still, he sees growing optimism as investors engage policymakers and prepare for a stronger market in 2026.
Tune in to learn how legal, regulatory, and investment forces are converging to shape the future of healthcare innovation!
Resources
2118 episodes
))
